Marie-laure Plissonnier

UMR Inserm 1052 CNRS 5286 Mixte CLB
Lyon, 69003, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Identification of Cyclin L1 as a Host Factor Regulating Hepatitis B Virus Replication.

Identification of Cyclin L1 as a Host Factor Regulating Hepatitis B Virus Replication.

Journal: Viruses

Published: March 31, 2026

Adenine Base Editing Potently Suppresses Hepatitis B Surface Antigen Expression and Inhibits Hepatitis D Virus Release.

Adenine Base Editing Potently Suppresses Hepatitis B Surface Antigen Expression and Inhibits Hepatitis D Virus Release.

Journal: bioRxiv : the preprint server for biology

Published: February 12, 2026

Clinical Trial: Hepatitis B Virus Genotype and a Combination of End-of-Treatment Biomarkers Predict Severe Flares After Nucleos(t)ide Analogue Cessation.

Clinical Trial: Hepatitis B Virus Genotype and a Combination of End-of-Treatment Biomarkers Predict Severe Flares After Nucleos(t)ide Analogue Cessation.

Journal: Alimentary pharmacology & therapeutics

Published: September 04, 2025

Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis B.

Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis B.

Journal: Journal of hepatology

Published: July 28, 2025

Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe.

Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe.

Journal: JHEP reports : innovation in hepatology

Published: June 20, 2025

Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.

Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.

Journal: Journal of hepatology

Published: April 11, 2025

Protocol for isolating CD163+ Kupffer cells from human liver resections.

Protocol for isolating CD163+ Kupffer cells from human liver resections.

Journal: STAR protocols

Published: July 19, 2024

Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta.

Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta.

Journal: Journal of hepatology

Published: May 05, 2024

Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptors.

Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptors.

Journal: JHEP reports : innovation in hepatology

Published: February 27, 2024

HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx.

HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx.

Journal: JHEP reports : innovation in hepatology

Published: December 03, 2023

Circulating HBV RNA and Hepatitis B Core-Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir Therapy.

Circulating HBV RNA and Hepatitis B Core-Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir Therapy.

Journal: The Journal of infectious diseases

Published: November 02, 2023

TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism.

TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism.

Journal: Gut

Published: October 24, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026